The Efficacy of Off-Label Abrocitinib in Alopecia Areata: A Systematic Review

Abstract

Keywords

abrocitinib alopecia areata alopecia universalis alopecia totalis autoimmune alopecia Janus kinase inhibitor

Get full access to this article

View all access options for this article.

References

Lepe

Syed

Zito

. Alopecia Areata. U.S. National Library of Medicine; 2024. Accessed November 12, 2024. https://www.ncbi.nlm.nih.gov/books/NBK537000/

Lee

W-S.

Comorbidities in alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):466-477.e16. doi:10.1016/j.jaad.2018.07.013

Mitroi

Ică

, et al Off-label uses of abrocitinib: review of emerging therapeutic applications beyond atopic dermatitis. Life. 2024;14(9):1127. doi:10.3390/life14091127

Wei

Chen

Shen

, et al Efficacy and safety of different JAK inhibitors in the treatment of alopecia areata: a network meta-analysis. Front Immunol. 2023;14:1152513. doi:10.3389/fimmu.2023.1152513

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.10 MB